| 摘要 |
<p>The present invention describes cyclic peptide compounds which modulate integrin mediated adhesion. These compounds can inhibit both β1 and β2 mediated adhesion. The invention further relates to therapeutic uses for these compounds in the treatment of adhesion related pathologies.</p> |
